Urogen Pharma
Urogen Pharma's email is info@urogen.com
and
Urogen Pharma's phone number is 1(646)768-9780
.
UroGen Pharma (formerly Theracoat ) (“UroGen” or “the Company”) is a clinical-stage biopharmaceutical company focused on developing novel therapies designed to change the standard of care for urological pathologies with a focus on uro-oncology. The Company has an innovative and broad pipeline of product candidates that it believes can overcome the deficiencies of current treatment options for a variety of urological conditions with a focus on uro-oncology. The lead product candidates, MitoGel and VesiGel, are proprietary formulations of the chemotherapy drug Mitomycin ...
read more
UroGen Pharma (formerly Theracoat ) (“UroGen” or “the Company”) is a clinical-stage biopharmaceutical company focused on developing novel therapies designed to change the standard of care for urological pathologies with a focus on uro-oncology. The Company has an innovative and broad pipeline of product candidates that it believes can overcome the deficiencies of current treatment options for a variety of urological conditions with a focus on uro-oncology. The lead product candidates, MitoGel and VesiGel, are proprietary formulations of the chemotherapy drug Mitomycin C, or MMC, a generic drug which is currently used off-label for urothelial cancer treatment in a water-based formulation as an adjuvant, post-surgery, therapy. The Company’s clinical stage pipeline includes Vesimune, its proprietary immunotherapy product candidate for the treatment of high-grade non-muscle invasive bladder cancer. In addition, BotuGel is a proprietary novel RTGel-based formulation of BOTOX, a branded drug, that it believes can potentially serve as an effective treatment option for patients suffering from overactive bladder. UroGen has licensed the worldwide rights to BotuGel to Allergan Pharmaceuticals International Limited, or Allergan, a wholly owned subsidiary of Allergan plc, which plans to commence a Phase 2 clinical trial of BotuGel.
show less
Website | urogen.com | |
Industry | Biotechnology | |
Location | New York, New York, United States | |
Employees | 155 | |
Founded | 2004 |
HQ | 499 Park Avenue Suite 1200 | |
Phone | 1(646)768-9780 | |
info@urogen.com | ||
Funding | 422,100,000 USD | |
Competitors | Roche, Agilent Technologies, Amgen, Genentech, Eurofins, Gilead Sciences, |
Website | urogen.com | |
Industry | Biotechnology | |
Location | New York, New York, United States | |
Employees | 155 | |
Founded | 2004 | |
linkedin.com/company/urogenpharma | ||
HQ | 499 Park Avenue Suite 1200 | |
Phone | 1(646)768-9780 | |
info@urogen.com | ||
Funding | 422,100,000 USD |
Email Patterns for Urogen Pharma
Top Competitors for Urogen Pharma
Urogen Pharma Questions
Where are Urogen Pharma's headquarters?
Urogen Pharma's headquarters are in 499 Park Avenue Suite 1200
What is Urogen Pharma's phone number?
Urogen Pharma's phone number is 1(646)768-9780
What is Urogen Pharma's official website?
Urogen Pharma's website is urogen.com
How many employees are working in Urogen Pharma right now?
Urogen Pharma has
155 employees.
View the Email and Phone Numbers for all 155 working at Urogen Pharma.
What is Urogen Pharma's industry?
Urogen Pharma's industry is
Biotechnology
Who are Urogen Pharma's top competitors?
Urogen Pharma's top competitors are
Roche
,
Agilent Technologies
,
Amgen
,
Genentech
,
Eurofins
,
Gilead Sciences
What is Urogen Pharma's email address?
Urogen Pharma's email address is info@urogen.com
What are Urogen Pharma's categories?
Urogen Pharma's categories are Biopharma, Biotechnology, Clinical Trials, Life Science, Pharmaceutical
What is Urogen Pharma's location?
Urogen Pharma's location is
New York, New York, United States
When was Urogen Pharma's founded?
Urogen Pharma's founding year is 2004
What is Urogen Pharma's funding?
Urogen Pharma's funding is 422,100,000 USD
What is Urogen Pharma's current status?
Urogen Pharma's current status is ipo
Top Urogen Pharma Employees
Field Reimbursement Manager
eknipfer@dendreon.com
+1772-344-2278
Vice President, Head Of Marketing
thomas.woodworth@bayer.com
+1862-404-5240
Vice President Supply Chain
p.maruszewski@eurand.com
+1937-898-9669
Territory Business Manager
fwalenter@aol.com
+1925-361-0121
Field Reimbursement Manager
kate.gruber@xcenda.com
+1920-238-0838
Chief Executive Officer
liz.barrett@pfizer.com
+1212-573-3115
Manager, Patient Engagement
carriejgoodman@gmail.com
+1212-463-3414